Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Open House Drug Discount Agreements For The Active Ingredient Bexarotene, Atc L01xf03 2026-04-21
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph. 8 Sgb V On The Active Ingredient Aflibercept (except 114.3 Mg/ml), Atc S01la05 For The Period December 1st, 2025 November 30th, 2027 2026-04-21
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130a Paragraph. 8 Sgb V On Medicines (openhouse Procedure) 2026-04-21
Germany The Health Insurance Companies Aim To Conclude Discount Contracts With All Suitable Pharmaceutical Companies According To § 130a Abs. 8 Sgb V For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal Pro 2026-04-21
Germany The Health Insurance Companies Aim To Conclude Discount Contracts With All Suitable Pharmaceutical Companies According To § 130a Abs. 8 Sgb V For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal Pro 2026-04-21
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130a Paragraph. 8 Sgb V On The Active Ingredients Mentioned With The Possibility Of Contracting Within The Framework Of The So-called Openhouse Procedure. 2026-04-21
Germany The Dak-gesundheit Intends To Conclude A Non-exclusive Discount Agreement Under § 130a Abs. 8 Sgb V For The Active Ingredient Doravirin, Atc J05ag06, For The Period From 01.12.2025 To 30.11.2027. This Involves Establishing Framework Discount Contracts For 2026-04-21
Germany The Health Insurance Companies Aim To Conclude Discount Contracts With All Suitable Pharmaceutical Companies According To § 130a Abs. 8 Sgb V For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal Pro 2026-04-21
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph. 8 Sgb V On The Active Ingredient Leuprorelin, Atc L02ae02 For The Period December 1st, 2025 November 30th, 2027 2026-04-21
Germany Rivaroxaban (solid Oral Drf; Only For Hkk: Only Potency 2.5 Mg)_tk, Hek, Hkk 2026-04-21
Whats app